Our data suggest that ICOS plays an important role in the immunopathogenesis of SLE and support the possibility that blockade of the interaction between ICOS and B7RP-1 may have therapeutic value in treating this intractable autoimmune disorder. This evidence concerns the gene ICOS and autoimmune disease.